Life Healthcare Group stock analysis
Want to see HK:0928 full AI Analyst Report?
Life Healthcare Group (0928) Stock Price & Analysis
0928 Stock Chart & Stats
- Day’s Range
- HKD 0.85 - HKD 0.94
- 52-Week Range
- HKD 0.33 - HKD 1.59
- Previous Close
- HKD 0.89
- Volume
- N/A
- Average Volume (3M)
- 364.96K
- Market Cap
- HKD 164.69M
- Enterprise Value
- HKD 218.74M
- Total Cash (Recent Filing)
- HKD 591.00K
- Total Debt (Recent Filing)
- HKD 2.11M
- Price to Earnings (P/E)
- 92.0
- Beta
- 0.65
- Next Earnings
- Nov 27, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound
The sharp 2026 revenue rebound indicates renewed demand for the group’s healthcare services and improved operating scale. If maintained, stronger volume can support better fixed-cost absorption, reinforce the hospital network’s market position, and provide a foundation for more consistent earnings over the next several quarters.
Very Low Leverage
Very low leverage materially reduces financial risk and preserves flexibility during periods of uneven profitability or cash generation. The sizeable equity base also provides a stronger solvency buffer, allowing the company to continue investing in its healthcare operations without the same refinancing pressure faced by highly indebted peers.
Return To Profitability
The return to positive EBIT and net income marks meaningful progress from the severe 2025 loss and demonstrates that the business can regain profitability when revenue improves. Although the recovery remains early, positive operating earnings create a platform for rebuilding margins and strengthening financial resilience.
Bears Say
Weak Cash Conversion
Persistent negative operating and free cash flow shows that reported profitability is not yet translating reliably into internally generated funds. This can constrain investment capacity, increase reliance on available liquidity, and make the recovery more vulnerable if weak cash conversion continues through the next several reporting periods.
Thin, Unstable Margins
The wide swings in net margin indicate that profitability has not yet stabilized at a durable level. A thin 1.3% margin leaves limited protection against operational setbacks, while the sharp deterioration from 2024 demonstrates that revenue recovery alone may not guarantee sustained earnings quality or dependable returns.
Weak Return On Equity
Repeatedly negative ROE followed by only a marginal 0.8% return suggests the company is not yet generating attractive profits from its substantial equity base. This weak capital productivity can limit retained-earnings growth and indicates that the turnaround still needs to deliver materially stronger profitability.
Life Healthcare Group News
King International Investment Cancels Rights Issue After Major Shareholders Breach Undertakings
The latest update is out from Life Healthcare Group ( ($HK:0928) ). King International Investment Limited has disclosed that two substantial shareholders, Mr. Wang Mengyao and Ms. Wei Yan, failed
King International Investment faces temporary non-compliance after independent director resigns
An update from Life Healthcare Group ( ($HK:0928) ) is now available. King International Investment Limited announced that independent non-executive director Lou Tao has resigned from the board and the
King International Wins Shareholder Backing for Share Consolidation and Major Rights Issue
Life Healthcare Group ( ($HK:0928) ) has issued an update. King International Investment Limited has secured shareholder approval for a share consolidation and a rights issue at an extraordinary general
King International Investment Sets AGM to Approve Accounts, Board Mandates and Share Issue Authority
An announcement from Life Healthcare Group ( ($HK:0928) ) is now available. King International Investment Limited has called its annual general meeting for 4 September 2026 in Hong Kong, where
0928 FAQ
What was Life Healthcare Group’s price range in the past 12 months?
What is Life Healthcare Group’s market cap?
When is Life Healthcare Group’s upcoming earnings report date?
How were Life Healthcare Group’s earnings last quarter?
Is Life Healthcare Group overvalued?
Does Life Healthcare Group pay dividends?
What is Life Healthcare Group’s EPS estimate?
How many shares outstanding does Life Healthcare Group have?
What happened to Life Healthcare Group’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Life Healthcare Group?
What is the TipRanks Smart Score and how is it calculated?
Life Healthcare Group Stock Smart Score
Company Description
Life Healthcare Group
King International Investment Limited operates as a holding company, with its core activities focused on the provision of healthcare products and related services. The firm's business interests are diversified, also encompassing money lending and the distribution of alcoholic beverages. Its geographical reach extends across both mainland China and Hong Kong. Established on March 12, 2001, the company maintains its headquarters in Hong Kong.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Yueyingtan Leng
- Employees
- 13
- Website
- www.kinginternational.hk
- Address
- HK
Life Healthcare Group (0928) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 5 | 1 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 12 | 0 | 0 |








